Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.215
+0.145 (3.56%)
At close: Sep 11, 2026, 4:00 PM EDT
4.110
-0.105 (-2.49%)
After-hours: Sep 11, 2026, 4:04 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $240.29 million as of September 11, 2026. Its market cap has increased by 184.84% in one year.
Market Cap
240.29M
Enterprise Value
50.31M
1-Year Change
184.84%
Ranking
Category
Stock Price
$4.22
ChartMarket Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $240.29M, a decrease of -55.57%. That is a compound annual growth rate of -14.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 240.29M | 110.69% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 264.19M |
| Indaptus Therapeutics | 246.50M |
| Niagen Bioscience | 245.81M |
| Invivyd | 243.41M |
| Surrozen | 243.06M |
| Compugen | 242.49M |
| Cellectis | 238.44M |
| Eledon Pharmaceuticals | 238.33M |